Literature DB >> 17409819

Pick the winner designs in phase II cancer clinical trials.

Sumithra J Mandrekar, Daniel J Sargent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17409819

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm.

Authors:  Roland B Walter; Frederick R Appelbaum; Martin S Tallman; Noel S Weiss; Richard A Larson; Elihu H Estey
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

2.  Statistical methods for down-selection of treatment regimens based on multiple endpoints, with application to HIV vaccine trials.

Authors:  Ying Huang; Peter B Gilbert; Rong Fu; Holly Janes
Journal:  Biostatistics       Date:  2017-04-01       Impact factor: 5.899

3.  Randomized phase II trials: time for a new era in clinical trial design.

Authors:  Sumithra J Mandrekar; Daniel J Sargent
Journal:  J Thorac Oncol       Date:  2010-07       Impact factor: 15.609

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.